Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics

Biochemistry, Genetics and Molecular Biology

• Lipid 100%
• Bioinformatics 100%
• Metabolic Pathway 66%
• Downregulation 66%
• Glycerol 66%
• Upregulation 66%
• Lipid Metabolism 66%
• Hub Genes 66%
• Sphingolipid 66%
• Phosphatidylinositol 66%
• Information Retrieval 33%
• Tumor Progression 33%
• Phospholipid Metabolism 33%
• Avidity 33%
• Peroxisome Proliferator-Activated Receptor 33%
• Steroid Biosynthesis 33%
• Overall Survival 33%
• Bioinformatics Software 33%
• Genomics 33%
• Phospholipid 33%
• Differentially Expressed Gene 33%
• Protein-Protein Interaction Networks 33%

Keyphrases

• Metabolic Biomarkers 100%
• Lipid Metabolic 100%
• Integrated Bioinformatics Analysis 100%
• Novel Lipids 100%
• Adrenocortical Carcinoma 100%
• Tumor 18%
• Glycerol 18%
• Survival Analysis 18%
• Database for Annotation 18%
• Lipid Metabolism Genes 18%
• Hub Genes 18%
• Correlation Engine 18%
• Lipids 9%
• Meta-analysis 9%
• Metabolism 9%
• Cholesterol 9%
• Differentially Expressed 9%
• 5-year Survival 9%
• Fatty Acid Metabolism 9%
• Tumor Progression 9%
• Glycerol-3-phosphate Dehydrogenase 9%
• Phospholipid Metabolism 9%
• Poor Survival 9%
• Genomic Analysis 9%
• Peroxisome Proliferator-activated Receptor 9%
• Protein-protein Interaction Network 9%
• Cancer Genome Atlas 9%
• Phosphatidylinositol 9%
• Program Data 9%
• Overall Survival 9%
• Sphingolipids 9%
• Lipid Biomarkers 9%
• Phospholipase D1 (PLD1) 9%
• Phospholipid Fatty Acids 9%
• Sphingolipid Metabolism 9%
• Differentially Regulated Genes 9%
• DGAT1 9%
• Search Tools 9%
• Enrichment Analysis 9%
• Tumor Therapy 9%
• Cytoscape 9%
• Therapy Resistance 9%
• Advanced or Metastatic 9%
• PIK3CB 9%
• Enrichment Pathway Analysis 9%
• Steroid Synthesis 9%
• S1P-lyase (SGPL1) 9%
• FDFT1 9%
• PLA2G16 9%
• Phosphatidylinositol Metabolism 9%
• Xena 9%
• PIK3CD 9%